Attitudes toward Catheter Ablation for Atrial Fibrillation: A Nationwide Survey among Danish Cardiologists

Background Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians’ attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first study to examine the attitudes of Danish cardiologist...

Full description

Saved in:
Bibliographic Details
Published inPacing and clinical electrophysiology Vol. 38; no. 10; pp. 1166 - 1172
Main Authors VADMANN, HENRIK, PEDERSEN, SUSANNE S., NIELSEN, JENS COSEDIS, RODRIGO-DOMINGO, MARIA, PEHRSON, STEEN, JOHANNESSEN, ARNE, HANSEN, PETER STEEN, JOHANSEN, JENS BROCK, RIAHI, SAM
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.10.2015
Subjects
Online AccessGet full text
ISSN0147-8389
1540-8159
DOI10.1111/pace.12682

Cover

Loading…
Abstract Background Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians’ attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first study to examine the attitudes of Danish cardiologists toward catheter ablation for AF, using a nationwide survey. Methods and Results We developed a purpose‐designed questionnaire to evaluate attitudes toward catheter ablation for AF that was sent to all Danish cardiologists (n = 401; response n = 272 (67.8%)). There was no association between attitudes toward ablation and the experience or age of the cardiologist with respect to patients with recurrent AF episodes with a duration of <48 hours or >7 days and/or need for cardioversion. The majority (69%) expected a recurrence of AF after catheter ablation in more than 30% of the cases. For patients with persistent longstanding AF with a duration of >1 year, the attitude toward ablation for longstanding AF was more likely to be positive with increasing age (P < 0.01) and years of experience of the cardiologist (P = 0.002). Conclusions Danish cardiologists generally have a positive attitude toward catheter ablation for AF, maintain up‐to‐date knowledge of the procedure, and are aware what information on ablation treatment should be given to patients with AF. The cardiologists had a positive attitude toward ablation for AF in patients with AF episodes <48 hours and patients with episodes >7 days, or those who needed medical/electrical conversion, but a more negative attitude toward treating longstanding AF patients.
AbstractList BACKGROUNDCatheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians' attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first study to examine the attitudes of Danish cardiologists toward catheter ablation for AF, using a nationwide survey.METHODS AND RESULTSWe developed a purpose-designed questionnaire to evaluate attitudes toward catheter ablation for AF that was sent to all Danish cardiologists (n = 401; response n = 272 (67.8%)). There was no association between attitudes toward ablation and the experience or age of the cardiologist with respect to patients with recurrent AF episodes with a duration of <48 hours or >7 days and/or need for cardioversion. The majority (69%) expected a recurrence of AF after catheter ablation in more than 30% of the cases. For patients with persistent longstanding AF with a duration of >1 year, the attitude toward ablation for longstanding AF was more likely to be positive with increasing age (P < 0.01) and years of experience of the cardiologist (P = 0.002).CONCLUSIONSDanish cardiologists generally have a positive attitude toward catheter ablation for AF, maintain up-to-date knowledge of the procedure, and are aware what information on ablation treatment should be given to patients with AF. The cardiologists had a positive attitude toward ablation for AF in patients with AF episodes <48 hours and patients with episodes >7 days, or those who needed medical/electrical conversion, but a more negative attitude toward treating longstanding AF patients.
Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians' attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first study to examine the attitudes of Danish cardiologists toward catheter ablation for AF, using a nationwide survey. We developed a purpose-designed questionnaire to evaluate attitudes toward catheter ablation for AF that was sent to all Danish cardiologists (n = 401; response n = 272 (67.8%)). There was no association between attitudes toward ablation and the experience or age of the cardiologist with respect to patients with recurrent AF episodes with a duration of <48 hours or >7 days and/or need for cardioversion. The majority (69%) expected a recurrence of AF after catheter ablation in more than 30% of the cases. For patients with persistent longstanding AF with a duration of >1 year, the attitude toward ablation for longstanding AF was more likely to be positive with increasing age (P < 0.01) and years of experience of the cardiologist (P = 0.002). Danish cardiologists generally have a positive attitude toward catheter ablation for AF, maintain up-to-date knowledge of the procedure, and are aware what information on ablation treatment should be given to patients with AF. The cardiologists had a positive attitude toward ablation for AF in patients with AF episodes <48 hours and patients with episodes >7 days, or those who needed medical/electrical conversion, but a more negative attitude toward treating longstanding AF patients.
Background Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians’ attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first study to examine the attitudes of Danish cardiologists toward catheter ablation for AF, using a nationwide survey. Methods and Results We developed a purpose‐designed questionnaire to evaluate attitudes toward catheter ablation for AF that was sent to all Danish cardiologists (n = 401; response n = 272 (67.8%)). There was no association between attitudes toward ablation and the experience or age of the cardiologist with respect to patients with recurrent AF episodes with a duration of <48 hours or >7 days and/or need for cardioversion. The majority (69%) expected a recurrence of AF after catheter ablation in more than 30% of the cases. For patients with persistent longstanding AF with a duration of >1 year, the attitude toward ablation for longstanding AF was more likely to be positive with increasing age (P < 0.01) and years of experience of the cardiologist (P = 0.002). Conclusions Danish cardiologists generally have a positive attitude toward catheter ablation for AF, maintain up‐to‐date knowledge of the procedure, and are aware what information on ablation treatment should be given to patients with AF. The cardiologists had a positive attitude toward ablation for AF in patients with AF episodes <48 hours and patients with episodes >7 days, or those who needed medical/electrical conversion, but a more negative attitude toward treating longstanding AF patients.
Author PEDERSEN, SUSANNE S.
PEHRSON, STEEN
HANSEN, PETER STEEN
VADMANN, HENRIK
RIAHI, SAM
JOHANSEN, JENS BROCK
NIELSEN, JENS COSEDIS
RODRIGO-DOMINGO, MARIA
JOHANNESSEN, ARNE
Author_xml – sequence: 1
  givenname: HENRIK
  surname: VADMANN
  fullname: VADMANN, HENRIK
  organization: Department of Cardiology, Aalborg AF Study Group, Center for Cardiovascular Research, Aalborg University Hospital, Aalborg, Denmark
– sequence: 2
  givenname: SUSANNE S.
  surname: PEDERSEN
  fullname: PEDERSEN, SUSANNE S.
  organization: Department of Cardiology, Odense University Hospital, Odense, Denmark
– sequence: 3
  givenname: JENS COSEDIS
  surname: NIELSEN
  fullname: NIELSEN, JENS COSEDIS
  organization: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
– sequence: 4
  givenname: MARIA
  surname: RODRIGO-DOMINGO
  fullname: RODRIGO-DOMINGO, MARIA
  organization: Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark
– sequence: 5
  givenname: STEEN
  surname: PEHRSON
  fullname: PEHRSON, STEEN
  organization: Department of Cardiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
– sequence: 6
  givenname: ARNE
  surname: JOHANNESSEN
  fullname: JOHANNESSEN, ARNE
  organization: Department of Cardiology, Gentofte Hospital, Gentofte, Denmark
– sequence: 7
  givenname: PETER STEEN
  surname: HANSEN
  fullname: HANSEN, PETER STEEN
  organization: Varde Heart Center, Varde, Denmark
– sequence: 8
  givenname: JENS BROCK
  surname: JOHANSEN
  fullname: JOHANSEN, JENS BROCK
  organization: Department of Cardiology, Odense University Hospital, Odense, Denmark
– sequence: 9
  givenname: SAM
  surname: RIAHI
  fullname: RIAHI, SAM
  email: sar@rn.dk
  organization: Department of Cardiology, Aalborg AF Study Group, Center for Cardiovascular Research, Aalborg University Hospital, Aalborg, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26096979$$D View this record in MEDLINE/PubMed
BookMark eNp9kMFu1DAQhi1URLeFCw-AfERIKfbGdmxu0bbdVl0tIEAgLpYTT1qXbLzYDsu-PW7T9ogv4xl9_2j0HaGDwQ-A0GtKTmh-77emhRM6F3L-DM0oZ6SQlKsDNCOUVYUspTpERzHeEkIEYfwFOpwLooSq1Azd1im5NFqIOPmdCRYvTLqBBAHXTW-S8wPufG5ScKbH564Jrp_mH3CN1_e_nbOAv4zhD-yx2fjhGp-awcWbvCtY53t_7WKKL9HzzvQRXj3UY_Tt_Ozr4qJYfVxeLupV0ZZKzAugnCveSiFF27FW5UMZUMa5lRI6LpuSEcEVYaaSylhqu6azjTRSMVJVsi2P0dtp7zb43yPEpDcutpCvHsCPUdOKSkUJVSKjbx7QsdmA1dvgNibs9aOfDLybgDb4GAN0Twgl-k6-vpOv7-VnmE7wzvWw_w-pP9WLs8dMMWWyIfj7lDHhlxZVWXH9fb3Un69-rk9XFz_0svwHNtuVuQ
Cites_doi 10.1016/j.cjca.2013.06.006
10.1161/JAHA.114.000881
10.1161/CIRCULATIONAHA.108.772582
10.1093/europace/euq404
10.1016/j.ahj.2008.12.011
10.1016/j.ahj.2015.03.006
10.1093/eurheartj/ehs253
10.1016/S0735-1097(03)00577-1
10.1016/j.pec.2012.05.011
10.5694/j.1326-5377.2007.tb00856.x
10.1093/eurheartj/ehl176
10.1093/europace/euu188
10.1161/CIRCULATIONAHA.113.005119
10.1093/eurheartj/ehi825
10.1056/NEJMoa1113566
10.1186/1471-2261-13-78
ContentType Journal Article
Copyright 2015 Wiley Periodicals, Inc.
Copyright_xml – notice: 2015 Wiley Periodicals, Inc.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/pace.12682
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1540-8159
EndPage 1172
ExternalDocumentID 26096979
10_1111_pace_12682
PACE12682
ark_67375_WNG_QKZNDLHX_G
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Denmark
GeographicLocations_xml – name: Denmark
GrantInformation_xml – fundername: Danish Council for Strategic Research
  funderid: 09‐066965
GroupedDBID ---
.3N
.GA
.Y3
04C
05W
0R~
10A
123
1OB
1OC
29O
2QV
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOJX
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMSDO
BMXJE
BPMNR
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DXH
EAD
EAP
EAS
EBC
EBD
EBS
ECF
ECT
ECV
EIHBH
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
I-F
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
VVN
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQ9
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3962-e15595c8686cf4c99694e1455d88ef58b34065904a789ad1dfbfdb8a8940778c3
IEDL.DBID DR2
ISSN 0147-8389
IngestDate Fri Jul 11 05:24:39 EDT 2025
Thu Apr 03 07:00:48 EDT 2025
Tue Jul 01 01:28:58 EDT 2025
Wed Jan 22 17:01:11 EST 2025
Wed Oct 30 09:57:15 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords atrial fibrillation
catheter ablation
cardiologist
attitudes
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2015 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3962-e15595c8686cf4c99694e1455d88ef58b34065904a789ad1dfbfdb8a8940778c3
Notes ark:/67375/WNG-QKZNDLHX-G
Danish Council for Strategic Research - No. 09-066965
ArticleID:PACE12682
istex:FCD83A678D07806E8B7B30EA7EFA7851EE44DE2B
Funding source: This study was supported by a research grant from the Danish Council for Strategic Research (grant number 09‐066965).
Disclosures: None.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26096979
PQID 1718910196
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1718910196
pubmed_primary_26096979
crossref_primary_10_1111_pace_12682
wiley_primary_10_1111_pace_12682_PACE12682
istex_primary_ark_67375_WNG_QKZNDLHX_G
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2015
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: October 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Pacing and clinical electrophysiology
PublicationTitleAlternate Pacing and Clinical Electrophysiology
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Bulkovand V, Fiala M, Havránek S, Simek J, Skňouřil L, Januška J, Spinar J, et al. Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: A prospective study with 3-year follow-up. J Am Heart Assoc 2014; 3:e000881.
Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42:185-197.
Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008; 118:2498-2505.
Neyt M, VanBrabandt H, Devos C. The cost-utility of catheter ablation of atrial fibrillation: A systematic review and critical appraisal of economic evaluations. BMC Cardiovasc Disord 2013; 13:78.
Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: Views of health professionals, older patients and their carers. Med J Aust 2007; 186:175-180.
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al. Task Force on Practice Guidelines, American College of Cardiology/American Heart Association, Committee for Practice Guidelines, European Society of Cardiology, European Heart Rhythm Association, Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006; 27:1979-2030.
Camm AJ, Lip GY, DeCaterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, et al. ESC Committee for Practice Guidelines (CPG). 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33:2719-2747.
Kelley AS, Reid MC, Miller DH, Fins JJ, Lachs MS. Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey. Am Heart J 2009; 157:702-708.
Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, et al. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: Results from a MANTRA-PAF substudy. Europace 2014; 17:48-55.
Sinner MF, Piccini JP, Greiner MA, Walkey AJ, Wallace ER, Heckbert SR, Benjamin ER, et al. Geographic variation in the use of catheter ablation for atrial fibrillation among Medicare beneficiaries. Am Heart J 2015; 169:775-782.
Mantovan R, Macle L, DeMartino G, Chen J, Morillo CA, Novak P, Calzolari V, et al. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: Substudy of the STAR AF randomized trial. Can J Cardiol 2013; 29:1211-1217.
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation 2014; 129:837-847.
Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012; 367:1587-1595.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, vanHerpen G, Stricker BH, Stijnen T, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006; 27:949-953.
Johansen JB, Mortensen PT, Videbaek R, Riahi S, Moller M, Haarbo J, Pedersen SS. Attitudes towards implantable cardioverter-defibrillator therapy: A national survey in Danish health-care professionals. Europace 2011; 13:663-667.
Borg Xuereb C, Shaw RL, Lane DA. Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesis. Patient Educ Couns 2012; 88:330-337.
2014; 129
2013; 29
2014; 3
2013; 13
2015; 169
2006; 27
2007; 186
2008; 118
2009; 157
2011; 13
2014
2014; 17
2012; 367
2012; 33
2012; 88
2003; 42
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
References_xml – reference: Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: Views of health professionals, older patients and their carers. Med J Aust 2007; 186:175-180.
– reference: Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008; 118:2498-2505.
– reference: Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation 2014; 129:837-847.
– reference: Borg Xuereb C, Shaw RL, Lane DA. Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesis. Patient Educ Couns 2012; 88:330-337.
– reference: Mantovan R, Macle L, DeMartino G, Chen J, Morillo CA, Novak P, Calzolari V, et al. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: Substudy of the STAR AF randomized trial. Can J Cardiol 2013; 29:1211-1217.
– reference: Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al. Task Force on Practice Guidelines, American College of Cardiology/American Heart Association, Committee for Practice Guidelines, European Society of Cardiology, European Heart Rhythm Association, Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006; 27:1979-2030.
– reference: Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42:185-197.
– reference: Sinner MF, Piccini JP, Greiner MA, Walkey AJ, Wallace ER, Heckbert SR, Benjamin ER, et al. Geographic variation in the use of catheter ablation for atrial fibrillation among Medicare beneficiaries. Am Heart J 2015; 169:775-782.
– reference: Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, et al. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: Results from a MANTRA-PAF substudy. Europace 2014; 17:48-55.
– reference: Heeringa J, van der Kuip DA, Hofman A, Kors JA, vanHerpen G, Stricker BH, Stijnen T, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006; 27:949-953.
– reference: Kelley AS, Reid MC, Miller DH, Fins JJ, Lachs MS. Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey. Am Heart J 2009; 157:702-708.
– reference: Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012; 367:1587-1595.
– reference: Camm AJ, Lip GY, DeCaterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, et al. ESC Committee for Practice Guidelines (CPG). 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33:2719-2747.
– reference: Neyt M, VanBrabandt H, Devos C. The cost-utility of catheter ablation of atrial fibrillation: A systematic review and critical appraisal of economic evaluations. BMC Cardiovasc Disord 2013; 13:78.
– reference: Bulkovand V, Fiala M, Havránek S, Simek J, Skňouřil L, Januška J, Spinar J, et al. Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: A prospective study with 3-year follow-up. J Am Heart Assoc 2014; 3:e000881.
– reference: Johansen JB, Mortensen PT, Videbaek R, Riahi S, Moller M, Haarbo J, Pedersen SS. Attitudes towards implantable cardioverter-defibrillator therapy: A national survey in Danish health-care professionals. Europace 2011; 13:663-667.
– volume: 27
  start-page: 1979
  year: 2006
  end-page: 2030
  article-title: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation‐executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)
  publication-title: Eur Heart J
– volume: 27
  start-page: 949
  year: 2006
  end-page: 953
  article-title: Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study
  publication-title: Eur Heart J
– volume: 13
  start-page: 663
  year: 2011
  end-page: 667
  article-title: Attitudes towards implantable cardioverter‐defibrillator therapy: A national survey in Danish health‐care professionals
  publication-title: Europace
– volume: 3
  start-page: e000881
  year: 2014
  article-title: Improvement in quality of life after catheter ablation for paroxysmal versus long‐standing persistent atrial fibrillation: A prospective study with 3‐year follow‐up
  publication-title: J Am Heart Assoc
– volume: 118
  start-page: 2498
  year: 2008
  end-page: 2505
  article-title: Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study
  publication-title: Circulation
– volume: 33
  start-page: 2719
  year: 2012
  end-page: 2747
  article-title: 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
  publication-title: Eur Heart J
– volume: 17
  start-page: 48
  year: 2014
  end-page: 55
  article-title: The cost‐effectiveness of radiofrequency catheter ablation as first‐line treatment for paroxysmal atrial fibrillation: Results from a MANTRA‐PAF substudy
  publication-title: Europace
– volume: 129
  start-page: 837
  year: 2014
  end-page: 847
  article-title: Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study
  publication-title: Circulation
– volume: 29
  start-page: 1211
  year: 2013
  end-page: 1217
  article-title: Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: Substudy of the STAR AF randomized trial
  publication-title: Can J Cardiol
– volume: 157
  start-page: 702
  year: 2009
  end-page: 708
  article-title: Implantable cardioverter‐defibrillator deactivation at the end of life: A physician survey
  publication-title: Am Heart J
– volume: 367
  start-page: 1587
  year: 2012
  end-page: 1595
  article-title: Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation
  publication-title: N Engl J Med
– volume: 169
  start-page: 775
  year: 2015
  end-page: 782
  article-title: Geographic variation in the use of catheter ablation for atrial fibrillation among Medicare beneficiaries
  publication-title: Am Heart J
– volume: 186
  start-page: 175
  year: 2007
  end-page: 180
  article-title: Management of warfarin in atrial fibrillation: Views of health professionals, older patients and their carers
  publication-title: Med J Aust
– year: 2014
  article-title: The EHRA White Book 2013. The current status of cardiac electrophysiology in ESC Member Countries
– volume: 13
  start-page: 78
  year: 2013
  article-title: The cost‐utility of catheter ablation of atrial fibrillation: A systematic review and critical appraisal of economic evaluations
  publication-title: BMC Cardiovasc Disord
– volume: 42
  start-page: 185
  year: 2003
  end-page: 197
  article-title: Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long‐term study
  publication-title: J Am Coll Cardiol
– volume: 88
  start-page: 330
  year: 2012
  end-page: 337
  article-title: Patients’ and health professionals’ views and experiences of atrial fibrillation and oral‐anticoagulant therapy: A qualitative meta‐synthesis
  publication-title: Patient Educ Couns
– ident: e_1_2_7_16_1
  doi: 10.1016/j.cjca.2013.06.006
– ident: e_1_2_7_17_1
  doi: 10.1161/JAHA.114.000881
– ident: e_1_2_7_6_1
  doi: 10.1161/CIRCULATIONAHA.108.772582
– ident: e_1_2_7_10_1
– ident: e_1_2_7_14_1
  doi: 10.1093/europace/euq404
– ident: e_1_2_7_18_1
  doi: 10.1016/j.ahj.2008.12.011
– ident: e_1_2_7_11_1
  doi: 10.1016/j.ahj.2015.03.006
– ident: e_1_2_7_2_1
  doi: 10.1093/eurheartj/ehs253
– ident: e_1_2_7_7_1
  doi: 10.1016/S0735-1097(03)00577-1
– ident: e_1_2_7_13_1
  doi: 10.1016/j.pec.2012.05.011
– ident: e_1_2_7_12_1
  doi: 10.5694/j.1326-5377.2007.tb00856.x
– ident: e_1_2_7_15_1
  doi: 10.1093/eurheartj/ehl176
– ident: e_1_2_7_8_1
  doi: 10.1093/europace/euu188
– ident: e_1_2_7_3_1
  doi: 10.1161/CIRCULATIONAHA.113.005119
– ident: e_1_2_7_4_1
  doi: 10.1093/eurheartj/ehi825
– ident: e_1_2_7_5_1
  doi: 10.1056/NEJMoa1113566
– ident: e_1_2_7_9_1
  doi: 10.1186/1471-2261-13-78
SSID ssj0006045
Score 2.1045587
Snippet Background Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians’ attitudes...
Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians' attitudes toward...
BACKGROUNDCatheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians' attitudes...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1166
SubjectTerms Age Distribution
atrial fibrillation
Atrial Fibrillation - epidemiology
Atrial Fibrillation - surgery
Attitude of Health Personnel
attitudes
cardiologist
Cardiology - statistics & numerical data
Catheter Ablation
Clinical Competence - statistics & numerical data
Denmark
Female
Health Care Surveys
Humans
Male
Middle Aged
Patient Selection
Physicians - statistics & numerical data
Practice Patterns, Physicians' - statistics & numerical data
Quality of Life
Title Attitudes toward Catheter Ablation for Atrial Fibrillation: A Nationwide Survey among Danish Cardiologists
URI https://api.istex.fr/ark:/67375/WNG-QKZNDLHX-G/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpace.12682
https://www.ncbi.nlm.nih.gov/pubmed/26096979
https://www.proquest.com/docview/1718910196
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bSxwxFD6IQulLvbdjVVJafCjMspe5ZKQvg7ourS69SZdCCUkmwVZZy86sVn-95yQza5VSaN-GIROSnJzLN_nOCcArq2y7yLomjHVmQsRf3VBJm4YIgDJrNY8kp-Tk42EyOInejuLRHLxpcmF8fYjZDzfSDGevScGlKn9TcoSUptXpJpwMMJG1KCL6eFc7KmlHNX8RzTC65bo2KdF47j69540WaGF__SnUvB-5OtfTX4RvzaA94-SsNa1US988qOf4v7Nagid1TMpyv4mWYc6MV-DRcX3qvgo_8ooIBYUpWeVYtszlDaJEWK48l45h7MtydwUI61MWwbl_v8ty5ktvX30vDPs0nVyaa-ZuOGKU3V6eYl_EiPWZSOUanPQPPu8NwvqOhlD3sqQbGjrWjDVPeKJtpBE9ZZGh4ucF58bGXPUiOrltRzLlmSw6BW6OQnHJM0SSKde9dZgfX4zNM2BaWYNY3XZMihgtVdJQ_l9qewjqFDrVAF42shI_fSkO0UAYWjbhli2AHSfGWRM5OSPyWhqLL8ND8eHd1-H-0WAkDgN40chZoErROYkcm4tpKTrorzGKQtsUwFO_AWa9IfzDKaZZAK-dGP8yEvE-3ztwTxv_0vg5PMagLPaEwU2YryZTs4WBT6W23Qa_BQzA_gQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZT9wwEB4hkCgvbWkLBAq4KupDpaz2yOH0LQKWpeyugIK64sWKHVvl0FJtsvT49Z2xs8uhCgneosixYo_tmc_zzQzAlpGmnidN7Ycq0T7ir6YvMxP7CIASYxQPMk7Byb1-1DkNvg7CQcXNoVgYlx9ieuFGO8Oe17TB6UL6zi5HTKlrjWbE8QSeo5LeVMBg5_g2e1RUDyoGIx7EqJir7KRE5Ln99p4-mqOp_f0_Y_O-7WqVT_uVq7Ba2JyFxDm5rI1LWVN_H2R0fPa4XsPLyixlqVtHizCjh29gvlc53t_CRVoSpyDXBSst0ZbZ0EEUCkulo9MxNH9ZaquAsDYFEly5919Yylz27V_nuWbfxqMb_YfZIkeMAtyLH9gXkWJdMFLxDk7buyfbHb8q0-CrVhI1fU2ezVDxiEfKBAoBVBJoyn-ec65NyGUrIOdtPchinmR5I8f1kUue8QTBZMxVawlmh9dDvQJMSaMRrpuGjhGmxTLTFAIYmxbiOol61YOPE2GJny4bh5igGJo2YafNg09WjtMm2eiS-GtxKL7398TRwVl_p9sZiD0PPkwELXBXkaskG-rrcSEaqLLRkMLjyYNltwKmvSECxCHGiQefrRwf-RNxmG7v2qfVpzTehBedk15XdPf7B2uwgDZa6PiD72G2HI31OtpBpdywq_0f4lICLQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEB9EQXyp1tq62mpKiw-FPe5jP7KlL4t6nlUPbRUPQcImm6C1nHK3p9W_3plk99RSBPu2LNmQZGYy89v8ZgLw2UhTz5Om9kOVaB_xV9OXmYl9BECJMYoHGafk5L1u1DkKvvfC3gR8q3JhXH2I8Q83sgy7X5OBX-XmkZEjpNS1RjPiuAFPBRFaC4VEPx6KR0X1oCQw4j6MfrksTko8nodvn7ijKVrZP_-KNZ-Grtb3tGfhtBq1o5xc1EaFrKm7vwo6_u-05uBVGZSy1GnRa5jQ_XmY3iuP3d_Ar7QgRkGuh6ywNFtmEwdRJCyVjkzHMPhlqb0DhLUpjeC3e_-VpczV3r45zzX7ORpc61tmrzhilN4-PMO-iBLrUpGGC3DU3jxc7_jlJQ2-aiVR09d0rhkqHvFImUAhfEoCTdXPc861CblsBXR0Ww-ymCdZ3shRO3LJM54glIy5ar2Fyf5lXy8CU9JoBOumoWMEabHMNCUAxqaFqE6iV_XgUyUrceVqcYgKw9CyCbtsHqxZMY6bZIMLYq_FoTjubomDnZPuxm6nJ7Y8-FjJWaBN0UFJ1teXo6FooMPGMAo3Jw_eOQUY94b4D6cYJx58sWJ8ZiRiP13ftE9LL2m8CtP7G22xu93dWYYZDNBCRx58D5PFYKQ_YBBUyBWr6_f5ewDl
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Attitudes+toward+Catheter+Ablation+for+Atrial+Fibrillation%3A+A+Nationwide+Survey+among+Danish+Cardiologists&rft.jtitle=Pacing+and+clinical+electrophysiology&rft.au=VADMANN%2C+HENRIK&rft.au=PEDERSEN%2C+SUSANNE+S.&rft.au=NIELSEN%2C+JENS+COSEDIS&rft.au=RODRIGO%E2%80%90DOMINGO%2C+MARIA&rft.date=2015-10-01&rft.issn=0147-8389&rft.eissn=1540-8159&rft.volume=38&rft.issue=10&rft.spage=1166&rft.epage=1172&rft_id=info:doi/10.1111%2Fpace.12682&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_pace_12682
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0147-8389&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0147-8389&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0147-8389&client=summon